# Omvoh

NDC: 0002-7575
Generic name: mirikizumab-mrkz
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20231026

FDA application: BLA761279

## Active ingredients

- MIRIKIZUMAB: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-7575"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-7575
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=472cbe04-263e-433d-9a0f-58c1b50b715a